Company: BLNE
Filing Date: 2025-03-10
Form Type: 424B7
Source: 0001493152-25-009637
Chunk: 6

Company: Beeline Holdings, Inc.
Filing Date: 2025-03-10
Form: 424B7
Chunk 6
---
 this prospectus supplement and incorporated by reference into this            
 prospectus supplement, and the other reports incorporated by reference into the accompanying prospectus for a discussion of factors you 
 should carefully consider before deciding to invest in our common stock.                                                                |

| S-9 |

The number of shares common stock to be outstanding immediately after this offering is based on 60,780,152 shares of common stock outstanding as of March 7, 2025 and excludes, as of that date:

| ● | 27,446,295 shares                                                   
 of common stock underlying outstanding convertible preferred stock; |

| ● | 6,163,064                                                                   
 shares of common stock issuable upon the exercise of outstanding warrants ; |

| ● | 1,042                                                                               
 shares of common stock issuable upon the exercise of outstanding stock options; and |

| ● | Up                                                                                    
 to 12,000,000 shares of common stock available for issuance pursuant to the Company’s 
 2025 Equity Incentive Plan.                                                           |

The share amounts, and conversion and exercise prices reflected above and elsewhere in this prospectus supplement do not give effect (except as otherwise noted) to (i) the 1-for-10 reverse stock split effective at 12:01 am ET on March 12, 2025, (ii) an estimated 3,887,847 options and an estimated 287,094 warrants which we are obligated to issue to former Beeline option holders and warrant holders, respectively, as a result of the Merger, or (iii) potential adjustment to the numbers of conversion and exercise prices and underlying shares pursuant to provisions in the respective securities described herein.

<div align='center'>THE PURCHASE AGREEMENT</div>

On December 31, 2024, we entered into a Common Stock Purchase Agreement, as amended and restated on March 7, 2025, with the selling stockholder pursuant to which the selling stockholder has agreed to purchase from us up to $10,000,000 of our common stock (subject to certain limitations). Also on December 31, 2024, we entered into a Registration Rights Agreement, as amended and restated on March 7, 2025 (“Registration Rights Agreement”), with the selling stockholder, pursuant to which we agreed to file a registration statement with the SEC to register the selling stockholder’s resale of shares of common stock issuable by us pursuant to the Purchase Agreement. Pursuant to the Registration Rights Agreement, we intend to file a registration statement on